Citius Oncology, Inc. (CTOR)
1.13
0.00 (0.00%)
USD |
NASDAQ |
Dec 12, 12:52
Citius Oncology Cash from Investing (Quarterly): 0.00 for June 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | 0.00 |
| Amicus Therapeutics, Inc. | -1.299M |
| Soligenix, Inc. | -0.0006M |
| Tonix Pharmaceuticals Holding Corp. | -1.029M |
| GT Biopharma, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -0.3641M |
| Free Cash Flow to Firm (Quarterly) | 0.1691M |
| Free Cash Flow Yield | -0.45% |